Xwell (XWEL) Net Equity Issued and Repurchased (2011 - 2025)

Xwell (XWEL) posted Net Equity Issued and Repurchased of $3.7 million for Q1 2025, up 24.83% sequentially from $3.0 million in Q4 2018.

Xwell (XWEL) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends

Xwell has reported Net Equity Issued and Repurchased for 6 years, with the latest figure at $3.7 million in Q1 2025.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $3.7 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $3.7 million (up 170.42% YoY) and the FY2025 annual result came in at $3.7 million, up 176.38% from the prior year.
Net Equity Issued and Repurchased grew to $3.7 million in Q1 2025 per XWEL's latest filing, from $3.0 million in the prior quarter.
Over five years, Net Equity Issued and Repurchased peaked at $3.7 million in Q1 2025 and troughed at $3.7 million in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn	-
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn	-
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn	-
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn	-
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn	-
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn	-
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn	-
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn	-
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn	-
10	Xwell	8.44 Mn	-3.33 Mn	2.95 Mn	-

Download Data